New research has shown that human stem cells can restore vision in monkeys, paving the way for new treatment options.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline one-year results from ...

Oak Ridge Eye Center’s Dr. Thomas Dahl will speak at 1:30 p.m. Oct. 21, 2024. He will answer other eye health-related ...

Regeneron Pharmaceuticals Inc. (REGN) announced positive three-year (156-week) data for EYLEA HD (aflibercept) Injection 8 mg from an ...

Roche (RHHBY) announced positive topline one-year results from the open-label, single-arm phase IV ELEVATUM study evaluating Vabysmo ...

Data about higher doses that are injected less often come as the original 2-milligram dose of Eylea is facing an increasing ...

According to Research by SNS Insider, Dry AMD Market Growth is Driven by New Therapies, Geriatric Population Boom, and Advancements in R&D.Pune, Oct. 17, 2024 (GLOBE NEWSWIRE) -- SNS Insider reports ...

A recent study, published in the journal Nature looked into the six-month impact of switching to faricimab instead of ...

According to data presented in a late-breaking oral presentation at the American Academy of Ophthalmology 2024 Annual Meeting ...

The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with diabetic ...